A Clinical Study to Evaluate the Long-term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mg

NCT00171405 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
250
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis